Deckmann Natasha 4

What Happened Natasha Deckmann, a director of Option Care Health (OPCH), was granted a total of 9,841 restricted stock units (RSUs) on May 20, 2026. The grant consists of 8,997 RSUs reported at $0.00 (value disclosed in the filing as $200,000) plus 844 RSUs issued in lieu of cash retainer at $22.23 each (totaling $18,762). Combined reported value = $218,762. These were awards (transaction code A), not open-market purchases or sales.

Key Details

• Transaction date: 2026-05-20; Form 4 filed 2026-05-22 (timely within the standard 2-business-day window).
• Grant specifics: 8,997 RSUs (calculated as $200,000 based on closing price 5/20/2026) + 844 RSUs @ $22.23 = $18,762.
• Vesting: All RSUs vest in full on May 20, 2027 (per footnotes F1 & F2).
• Shares owned after transaction: not specified in the provided filing.
• Nature of transaction: awards as director compensation; not a sale or purchase of existing shares.

Context RSUs are compensation grants that convert to shares only after vesting; they do not represent an immediate market purchase and are commonly used for director pay. The portion issued in lieu of cash retainer means Deckmann accepted equity instead of cash fees for her board service. These grants are routine for corporate directors and do not by themselves indicate an insider buying or selling in the open market.